The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis

Emiralioglu N., YALÇIN E. E., Meral A., ŞENER B., Dogru D., Ozcelik U., ...Daha Fazla

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, cilt.41, sa.4, ss.419-423, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 4
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1111/jcpt.12407
  • Dergi Adı: JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.419-423
  • Anahtar Kelimeler: cystic fibrosis, early eradication, Pseudomonas aeruginosa, treatment, YOUNG-CHILDREN, RISK-FACTORS, INFECTION, COLONIZATION, ACQUISITION, PATHOPHYSIOLOGY
  • Hacettepe Üniversitesi Adresli: Evet

Özet

What is known and objectiveAntibiotic therapy aimed at eradicating Pseudomonas aeruginosa (Pa), and improved regimens to treat chronic Pa infection have played a major role in increasing the median survival of patients with cystic fibrosis (CF). However, different clinical centres use varying eradication regimens. The aim of this study was to evaluate the efficacy of multiple eradication treatments against initial Pa infection and to determine the factors affecting the treatment success.